Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Astrocytes in multiple sclerosis.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.

Pages